{"auto_keywords": [{"score": 0.00481495049065317, "phrase": "common_and_rare_genetic_variants"}, {"score": 0.003780286517897356, "phrase": "penalized_estimation_methods"}, {"score": 0.00363080961099728, "phrase": "genome-wide_association_studies"}, {"score": 0.003282383509542342, "phrase": "rare_variants"}, {"score": 0.0029672941061574375, "phrase": "new_strategy"}, {"score": 0.002682370021834353, "phrase": "simulated_and_real_data"}, {"score": 0.0024247382451294255, "phrase": "breast_cancer_data"}, {"score": 0.0023287359930308864, "phrase": "previous_results"}, {"score": 0.0021049977753042253, "phrase": "variant_effects"}], "paper_keywords": [""], "paper_abstract": "Motivation: This article extends our recent research on penalized estimation methods in genome-wide association studies to the realm of rare variants. Results: The new strategy is tested on both simulated and real data. Our findings on breast cancer data replicate previous results and shed light on variant effects within genes.", "paper_title": "Association screening of common and rare genetic variants by penalized regression", "paper_id": "WOS:000282170000003"}